<DOC>
	<DOCNO>NCT02872688</DOCNO>
	<brief_summary>The purpose study investigate effect GanedenBC30 , probiotic bacteria ( Bacillus coagulans strain GBI-30 , 6086 ) , gut microbiome healthy adult . Subjects complete 2-week run-in period prior receive GanedenBC30 . The study open-label subject act control microbiome unique individual . During run-in period , subject collect two stool sample complete daily bowel habit diary order understand usual habit profile microbiome subject . 30 subject take part research study conduct Nutrasource Diagnostics Inc . Subjects take GanedenBC30 four week . Stool sample collect end study daily bowel habit diary maintain duration study .</brief_summary>
	<brief_title>Influence GanedenBC30 ( Bacillus Coagulans GBI-30 , 6086 ) Gut Microbiome Healthy Adults</brief_title>
	<detailed_description />
	<criteria>Nonsmoker , exsmoker ≥6 month Body mass index 18.5 34.9 kg/m2 ( inclusive ) Female subject childbearing potential [ i.e . surgically sterilize postmenopausal ( great one year since last menses ) ] must negative urine pregnancy test must use effective birth control method Willing avoid alcohol consumption 24 h prior every clinic visit Willing maintain regimen dietary supplement know alter GI function ( include , limited , iron supplement calcium ) Willing maintain stable body weight , activity level dietary pattern except use study product , direct Willing able provide inform write consent Pregnancy lactation , subject unwilling take appropriate contraceptive duration study Use prescription drug ( birth control ) within 1 month prior visit 1b Use weightloss program weightloss medication ( prescription overthe counter ) include , limited , lipase inhibitor , within 3 month prior visit 1b Use overthecounter prescription laxatives stool softener within 1 month prior visit 1b Use antibiotic ( topical ) within 2 month prior visit 1b Use prebiotic supplement ( e.g . fructans galactooligosaccharides ( GOS ) , psyllium , fiber , inulin ) probiotic supplement ( i.e . live microorganism ) within 1 month visit 1b consumption yogurt food add prebiotics add probiotic within 2 week visit 1b History blood clot disorder use coagulationinhibiting drug ( e.g . warfarin ) Individuals achlorhydria Presence disease ( include , limited : diabetes , gastrointestinal disease , cardiovascular disease , pancreatic , renal , liver disease , chronic diarrhea constipation , irritable bowel syndrome , inflammatory bowel disease Abdominal gastrointestinal surgery within previous 12 month plan abdominal gastrointestinal surgery next 4 month Recent gastrointestinal foodborne illness ( within 1 month prior visit 1b ) History neurological disease ( e.g . Parkinson 's disease , stroke , traumatic brain injury , etc . ) History cancer ( exclude nonmelanoma skin cancer basal cell carcinoma ) past 5 year Controlled uncontrolled hypertension define seat rest systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg Abnormal laboratory test result clinical significance , include , limited ALT AST ≥1.5X upper limit normal screen Presence history ( past 6 month ) alcohol drug abuse ; alcohol use &gt; 2 standard alcoholic drink per day Extreme dietary habit ( e.g . vegan low carbohydrate diet ) Subject know allergy intolerance soy Allergy intolerance contraindication rescue antibiotic regimen ( Ciprofloxacin Septra ( contains Trimethoprim ) Subject unwilling unable abide requirement protocol Any condition would interfere subject 's ability comply study instruction , might confound interpretation study , put subject risk Subject take investigational health product participate research study within 30 day prior first study visit</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>